Baxter (BAX) is a publicly traded Healthcare sector company. As of September 18, 2026, BAX trades at $22.82 with a market cap of $11.90B and a P/E ratio of -11.07. BAX moved -0.96% today. Year to date, BAX is +16.92%; over the trailing twelve months it is -3.76%. Its 52-week range spans $15.73 to $37.74. Analyst consensus is neutral with an average price target of $25.90. Rallies surfaces BAX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for BAX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $22.82 |
| Market Cap | $11.90B |
| P/E Ratio | -11.07 |
| EPS | $-2.07 |
| Dividend Yield | 0.01% |
| 52-Week High | $37.74 |
| 52-Week Low | $15.73 |
| Volume | 4.59M |
| Avg Volume | 0 |
| Revenue (TTM) | $11.47B |
| Net Income | $-1.06B |
| Gross Margin | 30.08% |
10 analysts cover BAX: 0 strong buy, 1 buy, 9 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $25.90.